TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32693563

Group type: EXPERIMENTAL
Intervention: Cooling intervention (COL) - cold-water ingestion, electric fan, ice-filled damp towel
Number of subjects: 8

Group type: COMPARATOR
Intervention: No cooling (CON)
Number of subjects: 8
Study: 35422766

Group type: EXPERIMENTAL
Intervention: 60 g/d of whey protein hydrolysate
Number of subjects: 64

Group type: COMPARATOR
Intervention: Maltodextrin with high (30 g/d) or low (10 g/d) dietary fiber intake
Number of subjects: 64
Study: 33899634

Group type: EXPERIMENTAL
Intervention: MTD loaded solid lipid nanoparticles (SLNs) vaginal emulgel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Marketed vaginal gel (Metron®)
Number of subjects: 0
Study: 34789067

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing integrated with Cognitive Behavioral Therapy (MI-CBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy alone (CBT-alone)
Number of subjects: 0
Study: 33812809

Group type: EXPERIMENTAL
Intervention: Patient navigation by a trained, lay postpartum navigator
Number of subjects: 0
Study: 36307514

Group type: EXPERIMENTAL
Intervention: Heated tobacco products
Number of subjects: 89

Group type: COMPARATOR
Intervention: Combustible cigarettes (CC)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Stopped smoking (SS)
Number of subjects: 89
Study: 34325923

Group type: EXPERIMENTAL
Intervention: Capsular tension ring (CTR) insertion before trifocal IOL implantation
Number of subjects: 86

Group type: COMPARATOR
Intervention: No capsular tension ring (CTR) insertion (Control group A)
Number of subjects: 86
Study: 33119121

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR) for 90 minutes per week for eight sessions
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 39
Study: 35456295

Group type: EXPERIMENTAL
Intervention: Paste-type Acellular Dermal Matrix (ADM)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Standard wound care
Number of subjects: 86
Study: 32175985

Group type: EXPERIMENTAL
Intervention: Quadratus lumborum block type 2 (QLB)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Transversus abdominis plane block (TAPB)
Number of subjects: 101
Study: 35274710

Group type: EXPERIMENTAL
Intervention: SOC + IO (mFOLFOX6 + Bevacizumab + Avelumab + CEA-targeted vaccine)
Number of subjects: 26

Group type: COMPARATOR
Intervention: SOC (mFOLFOX6 + Bevacizumab)
Number of subjects: 26
Study: 35968060

Group type: EXPERIMENTAL
Intervention: Chlorhexidine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Xylitol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Probiotic
Number of subjects: 60
Study: 32244205

Group type: EXPERIMENTAL
Intervention: CRASH risk score provided to doctors
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (doctors without CRASH risk score)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Surgery as the best next step
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: CRASH risk score for 14-day mortality
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: CRASH risk score for unfavorable outcome at 6 months
Number of subjects: 28
Study: 35351701

Group type: EXPERIMENTAL
Intervention: Targeted hypothermia (34°C-35°C)
Number of subjects: 516

Group type: COMPARATOR
Intervention: Normothermia (36.5°C-37.5°C)
Number of subjects: 516
Study: 33799307

Group type: EXPERIMENTAL
Intervention: Novel oral nutritional supplement (whey and casein protein, ursolic acid, free branch‐chained amino acids, vitamin D) for 12 weeks
Number of subjects: 82

Group type: COMPARATOR
Intervention: Standard oral nutritional supplement for 12 weeks
Number of subjects: 82
Study: 32527972

Group type: EXPERIMENTAL
Intervention: Endovascular thrombectomy (EVT)
Number of subjects: 380
Study: 35377332

Group type: EXPERIMENTAL
Intervention: SFSW parent training intervention (internet-based and telephone-assisted)
Number of subjects: 832
Study: 33990376

Group type: EXPERIMENTAL
Intervention: DD-focused OnTrack group
Number of subjects: 301

Group type: COMPARATOR
Intervention: education‐oriented KnowIt group
Number of subjects: 301
Study: 35316705

Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control
Number of subjects: 123

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 123
Study: 32749930

Group type: EXPERIMENTAL
Intervention: Coaching model of communication skills for oncologists
Number of subjects: 0
Study: 34929591

Group type: EXPERIMENTAL
Intervention: 0.2% Luteolin (LT) for 2 min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.4% Galangin (GL) for 2 min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1% Proanthocyanidin (PAC) for 2 min
Number of subjects: 0

Group type: COMPARATOR
Intervention: Phosphoric acid (PA) or ethylenediaminetetraacetic acid (EDTA) for demineralization
Number of subjects: 0
Study: 32289864

Group type: EXPERIMENTAL
Intervention: Prediction model for VTE
Number of subjects: 1359880
Study: 34429364

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg rhTNK-tPA (to a maximum of 40 mg)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: 0.25 mg/kg rhTNK-tPA (to a maximum of 40 mg)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: 0.32 mg/kg rhTNK-tPA (to a maximum of 40 mg)
Number of subjects: 236

Group type: COMPARATOR
Intervention: 0.9 mg/kg rt-PA (to a maximum of 90 mg)
Number of subjects: 236
Study: 33647734

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure management (SBP target <140 mmHg)
Number of subjects: 2792

Group type: COMPARATOR
Intervention: Guideline-recommended blood pressure management (SBP target <180 mmHg)
Number of subjects: 2792

Group type: EXPERIMENTAL
Intervention: Both groups (elevated body temperature <37.5 vs. ≥37.5 °C)
Number of subjects: 2792
Study: 32556055

Group type: EXPERIMENTAL
Intervention: Technique without the use of an interference screw (group A)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Technique with the use of an interference screw (group B)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Comparison between group A and group B
Number of subjects: 23
Study: 35152879

Group type: EXPERIMENTAL
Intervention: Machine learning methods for predicting death prognosis
Number of subjects: 246
Study: 34254658

Group type: EXPERIMENTAL
Intervention: 40 mg intrathecal meperidine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 50 mg intrathecal meperidine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 60 mg intrathecal meperidine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 70 mg intrathecal meperidine
Number of subjects: 60
Study: 34147830

Group type: EXPERIMENTAL
Intervention: Health care delivery structures focusing on mental illness identification
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Health assessment screening on arrival to the short-term custodial setting
Number of subjects: 37
Study: 32665394

Group type: EXPERIMENTAL
Intervention: Comprehensive ACP Program (includes clinician communication skills training and patient video decision aids)
Number of subjects: 11000
Study: 36038368

Group type: EXPERIMENTAL
Intervention: Specific Carbohydrate Diet (SCD)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Mediterranean Diet (MD)
Number of subjects: 100
Study: 34923962

Group type: EXPERIMENTAL
Intervention: Group C (Content learning, reflection and experiential practice)
Number of subjects: 528

Group type: COMPARATOR
Intervention: Group A (Content learning)
Number of subjects: 528

Group type: COMPARATOR
Intervention: Group B (Content learning and reflection)
Number of subjects: 528
Study: 34590418

Group type: EXPERIMENTAL
Intervention: Direct restorations (DRs) using light-cured composite (GrandioSO, VOCO)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Indirect restorations (IRs) using precured composite block (Grandio Blocs, VOCO)
Number of subjects: 30
Study: 32054897

Group type: EXPERIMENTAL
Intervention: GradientBoosting model
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: Logistic model
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: gbm model
Number of subjects: 999
Study: 34715522

Group type: EXPERIMENTAL
Intervention: Higher cf-PWV in males
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Higher cf-PWV in females
Number of subjects: 80
Study: 33383570

Group type: EXPERIMENTAL
Intervention: High carbohydrate diet (MAX = 10 g/kg body mass CHO daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Moderate carbohydrate control diet (CON = 6 g/kg body mass CHO daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Moderate carbohydrate control diet (CON)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High carbohydrate diet (MAX)
Number of subjects: 20
Study: 32947920

Group type: EXPERIMENTAL
Intervention: Cyclical Ketogenic Reduction Diet (CKD)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Nutritionally Balanced Reduction Diet (RD)
Number of subjects: 25
Study: 35325871

Group type: EXPERIMENTAL
Intervention: Argentine tango dance intervention (90 minutes, twice a week for 12 weeks)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (continued regular activities)
Number of subjects: 36
Study: 33822469

Group type: EXPERIMENTAL
Intervention: SAR425899 (0.12, 0.16 or 0.20 mg)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: liraglutide (1.80 mg)
Number of subjects: 70

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 70
Study: 36181473

Group type: EXPERIMENTAL
Intervention: Guilt proneness
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Shame proneness
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Failure priming
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Success priming
Number of subjects: 156
Study: 34374425

Group type: EXPERIMENTAL
Intervention: WRSS1 vaccine (3 doses of 3 × 106 CFU)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: WRSS1 vaccine (3 doses of 3 × 105 CFU)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: WRSS1 vaccine
Number of subjects: 2
Study: 36451722

Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg) added to 10 mg hyperbaric bupivacaine 0.5% with 5 µg sufentanil
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group received 10 mg hyperbaric bupivacaine 0.5% with 5 µg sufentanil and 2 ml normal saline
Number of subjects: 58
Study: 33849166

Group type: EXPERIMENTAL
Intervention: FEMALE health education
Number of subjects: 428

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 428
Study: 35279142

Group type: EXPERIMENTAL
Intervention: Daily supportive text messages (Text4Support) and mental health peer support
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: Daily supportive text messages (Text4Support)
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: Mental health peer support
Number of subjects: 10000
Study: 33942795

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32852343

Group type: EXPERIMENTAL
Intervention: Ultrathin-strut biodegradable polymer-coated sirolimus-eluting stent
Number of subjects: 0

Group type: COMPARATOR
Intervention: Very thin-strut durable polymer-coated everolimus-eluting stent
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ultrathin-strut DES
Number of subjects: 0
Study: 35838507

Group type: EXPERIMENTAL
Intervention: Biofeedback (BF) and Manual Therapy (MT) with Postural Exercises (PE)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Biofeedback (BF) and Manual Therapy (MT) with Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 31
Study: 32924240

Group type: EXPERIMENTAL
Intervention: Wing-retained FPDs
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Inlay-retained FPDs
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both designs
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Plaque, gingival, and periodontal scores
Number of subjects: 30
Study: 32343882

Group type: EXPERIMENTAL
Intervention: Sarilumab 200 mg
Number of subjects: 1144

Group type: COMPARATOR
Intervention: Adalimumab 40 mg
Number of subjects: 1144

Group type: EXPERIMENTAL
Intervention: Sarilumab 150 mg + Methotrexate
Number of subjects: 1144

Group type: EXPERIMENTAL
Intervention: Sarilumab 200 mg + Methotrexate
Number of subjects: 1144

Group type: COMPARATOR
Intervention: Placebo + Methotrexate
Number of subjects: 1144
Study: 33620076

Group type: EXPERIMENTAL
Intervention: Pulse Arrival Time (PAT)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: PAT index (PAT_I)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: PAT and PAT_I together
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control group (no hemorrhage)
Number of subjects: 5
Study: 34519802

Group type: EXPERIMENTAL
Intervention: Inosine (n = 149)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Placebo (n = 149)
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Inosine
Number of subjects: 298

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 298
Study: 35841234

Group type: EXPERIMENTAL
Intervention: Soticlestat (≤300 mg twice daily, weight-adjusted)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Soticlestat
Number of subjects: 141
Study: 32441386

Group type: EXPERIMENTAL
Intervention: Superficial cryotherapy (8 to 10 seconds freeze-thaw cycles)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Superficial cryotherapy (13 to 15 seconds freeze-thaw cycles)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Superficial cryotherapy (3 to 5 seconds freeze-thaw cycles)
Number of subjects: 75
Study: 32880803

Group type: EXPERIMENTAL
Intervention: Low-dose rivaroxaban
Number of subjects: 1248214
Study: 36257081

Group type: EXPERIMENTAL
Intervention: Time-restricted feeding (16/8) plus a low-sugar diet
Number of subjects: 0
Study: 32101488

Group type: EXPERIMENTAL
Intervention: Aloe-vera
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sodium bicarbonate 5%
Number of subjects: 26
Study: 34726808

Group type: EXPERIMENTAL
Intervention: NB-OMP (NB-UVB and dexamethasone oral mini-pulse therapy)
Number of subjects: 80

Group type: COMPARATOR
Intervention: NB-placebo (NB-UVB and placebo)
Number of subjects: 80
Study: 34348954

Group type: EXPERIMENTAL
Intervention: Recovery-focused therapy (RfT) for older adults with BD; specific dosage and duration not mentioned.
Number of subjects: 8
Study: 32586587

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg daily for 45 days
Number of subjects: 9812

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9812
Study: 34215025

Group type: EXPERIMENTAL
Intervention: Efpeglenatide (4 or 6 mg weekly subcutaneous injections)
Number of subjects: 4076

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4076
Study: 32346886

Group type: EXPERIMENTAL
Intervention: Proactive rapid genetic counseling and testing
Number of subjects: 320

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 320
Study: 35120127

Group type: EXPERIMENTAL
Intervention: CC-11050 (PDE4i)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: everolimus (mTORi)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: auranofin (oral gold salt)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: ergocalciferol (vitamin D)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control
Number of subjects: 200
Study: 33588908

Group type: EXPERIMENTAL
Intervention: Intravenous alteplase administration (IVT) at a dosage of 0.9 mg/kg followed by endovascular treatment (EVT)
Number of subjects: 540

Group type: COMPARATOR
Intervention: Direct endovascular treatment (EVT)
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Intravenous alteplase administration (IVT) followed by EVT
Number of subjects: 540
Study: 32190655

Group type: EXPERIMENTAL
Intervention: Sensory subthreshold TENS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sensory suprathreshold TENS
Number of subjects: 0
Study: 36384648

Group type: EXPERIMENTAL
Intervention: Telemedicine visit (Arm T)
Number of subjects: 46

Group type: COMPARATOR
Intervention: In-person visit (Arm I)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Telemedicine visit (Arm T) after second visit
Number of subjects: 46

Group type: COMPARATOR
Intervention: In-person visit (Arm I) after second visit
Number of subjects: 46
Study: 36217012

Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Myofascial release (MRT), muscle energy (MET), and soft tissue techniques (STT)
Number of subjects: 59
Study: 32114570

Group type: EXPERIMENTAL
Intervention: Mobile teledermoscopy
Number of subjects: 98
Study: 35967467

Group type: EXPERIMENTAL
Intervention: Dry needling under EMG guidance (DN-EMG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Dry needling without EMG guidance (DN)
Number of subjects: 30
Study: 33146620

Group type: EXPERIMENTAL
Intervention: Pregnant+ app and usual care
Number of subjects: 238

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 238
Study: 35505463

Group type: EXPERIMENTAL
Intervention: Individual hypnotherapy
Number of subjects: 119

Group type: COMPARATOR
Intervention: Group hypnotherapy
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 119
Study: 34978317

Group type: EXPERIMENTAL
Intervention: Training monitoring based on intensities around 400 m pace (92 and 97% of 400 m speed)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Different heart rate zones (EN2 and EN2+)
Number of subjects: 20
Study: 35685584

Group type: EXPERIMENTAL
Intervention: Adenovirus pneumonia
Number of subjects: 220

Group type: COMPARATOR
Intervention: Bacterial pneumonia
Number of subjects: 220
Study: 34129389

Group type: EXPERIMENTAL
Intervention: Aerosol therapy (specific medications not detailed)
Number of subjects: 1006

Group type: EXPERIMENTAL
Intervention: Bronchodilators
Number of subjects: 1006

Group type: EXPERIMENTAL
Intervention: Mucus-regulating agents
Number of subjects: 1006

Group type: EXPERIMENTAL
Intervention: Aerosol therapy (general)
Number of subjects: 1006
Study: 33402130

Group type: EXPERIMENTAL
Intervention: SOX
Number of subjects: 110

Group type: COMPARATOR
Intervention: mFOLFOX6
Number of subjects: 110
Study: 33350447

Group type: EXPERIMENTAL
Intervention: Rosuvastatin therapy for 48 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34171967

Group type: EXPERIMENTAL
Intervention: Group-based psychosocial intervention with weekly sessions for up to four weeks.
Number of subjects: 19
Study: 33825525

Group type: EXPERIMENTAL
Intervention: Outcome-based student assessment (OBSA)
Number of subjects: 233
Study: 35091853

Group type: EXPERIMENTAL
Intervention: Workplace health promotion (WHP) program including healthy mental health module, anxiety management technique, mindfulness for stress, and stress at work delivered through Occupational Stress Management Course and Employee Assistance Program.
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Workplace health promotion (WHP) program
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (general brochure on stress)
Number of subjects: 88
Study: 34216871

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 190

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 190
Study: 35805451

Group type: EXPERIMENTAL
Intervention: Clinical Pilates exercises combined with conventional physical therapy (CPT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional physical therapy (CPT)
Number of subjects: 40
Study: 32558050

Group type: EXPERIMENTAL
Intervention: Non-pharmacological interventions (including mindfulness and behavioural techniques)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interventions combining mindfulness and behavioural techniques
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-pharmacological interventions
Number of subjects: 0
Study: 35959221

Group type: EXPERIMENTAL
Intervention: Hysteroscopic cold broad sword play + drospirenone and ethinylestradiol tablets
Number of subjects: 108

Group type: COMPARATOR
Intervention: Hysteroscopic cold broad sword play + estrogen and progestin sequential therapy
Number of subjects: 108
Study: 33529095

Group type: EXPERIMENTAL
Intervention: Decompressive craniectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Maximum medical management
Number of subjects: 0
Study: 32306606

Group type: EXPERIMENTAL
Intervention: Robot-assisted surgery
Number of subjects: 130

Group type: COMPARATOR
Intervention: Laparoscopic surgery
Number of subjects: 130
Study: 35130956

Group type: EXPERIMENTAL
Intervention: Taped filter mask
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Surgical mask
Number of subjects: 8
Study: 33722075

Group type: EXPERIMENTAL
Intervention: ACC walking intervention
Number of subjects: 38

Group type: COMPARATOR
Intervention: SS walking intervention
Number of subjects: 38
Study: 33253970

Group type: EXPERIMENTAL
Intervention: Nutritional supplementation
Number of subjects: 1200000

Group type: EXPERIMENTAL
Intervention: Nutritional education
Number of subjects: 1200000

Group type: EXPERIMENTAL
Intervention: Management of malnutrition
Number of subjects: 1200000
Study: 33300382

Group type: EXPERIMENTAL
Intervention: Acupuncture intervention
Number of subjects: 106

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 106
Study: 34448354

Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation (ARP) using deproteinized bovine bone mineral containing 10% collagen (DBBM‐C) covered by a collagen membrane
Number of subjects: 14

Group type: COMPARATOR
Intervention: Spontaneous healing (control)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation (ARP)
Number of subjects: 14
Study: 36494823

Group type: EXPERIMENTAL
Intervention: Special orthopaedic geriatrics (SOG) care model
Number of subjects: 310

Group type: COMPARATOR
Intervention: Usual orthopaedic care without orthogeriatric co-management
Number of subjects: 310
Study: 33790039

Group type: EXPERIMENTAL
Intervention: INTRINSIC score (risk prediction score)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: INTRINSIC score <2
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: INTRINSIC score <3
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: INTRINSIC score
Number of subjects: 451
Study: 32421737

Group type: EXPERIMENTAL
Intervention: Helping Mothers Survive Bleeding after Birth training
Number of subjects: 636
Study: 35443813

Group type: EXPERIMENTAL
Intervention: Aerobic training (12 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Home-based exercise program (Control)
Number of subjects: 0
Study: 34252990

Group type: EXPERIMENTAL
Intervention: CLOSE protocol guided fixed 50 W HPSD
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard power settings (20 W posterior and 40 W roof and anterior wall)
Number of subjects: 40